Free shipping on all orders over $ 500

AM-2201

Cat. No. M2343

All AbMole products are for research use only, cannot be used for human consumption.

AM-2201 Structure
Size Price Availability Quantity
1mg USD 150 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AM-2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively. AM-2201 acts as a potent but nonselective full agonist for the cannabinoid receptor. The physiological actions and metabolism of AM2201 have not been characterized.

Customer Product Validations & Biological Datas
Source Drug Alcohol Depend (2017). Figure 2. AM2201
Method s.c.
Cell Lines Rats
Concentrations 0.1 – 0.3 mg/kg
Incubation Time 3 h
Results THC and XLR-11 were the least potent of the cannabinoids, while CP55,940 was the most potent. JWH-018 and AM2201 had comparable potency at increasing BP and were intermediate between CP55,940 and THC.
Chemical Information
Molecular Weight 359.44
Formula C24H22FNO
CAS Number 335161-24-5
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Hutter M, et al. J Mass Spectrom. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism.

[2] McQuade D, et al. Eur J Clin Pharmacol. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.

Related Cannabinoid Products
Org 27569

Org 27569 is a potent and selective allosteric modulator of the cannabinoid CB1 receptor.

AM1241

AM1241 is a cannabinoid CB2 receptor selective agonist.

CP 945598 hydrochloride

CP 945598 hydrochloride is a selective and high affinity CB1 antagonist (Ki values are 0.7 and 0.12 nM in binding and functional assays respectively).

AM251

AM251 block the inhibitory effects of endocannabinoids and synthetic cannabinoid agonists on transmitter release through an action at presynaptic cannabinoid 1 receptors in brain.

BML-190

BML-190 is a selective cannabinoid CB2 receptor inverse agonist with Ki of 435 nM, with 50-fold selectivity over CB1 receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: AM-2201 supplier, Cannabinoid, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.